Lack of association between a disease-susceptible single-nucleotide polymorphism, rs2230926 of TNFAIP3, and tumour necrosis factor inhibitor therapeutic failure in Japanese patients with rheumatoid arthritis

Scand J Rheumatol. 2020 May;49(3):253-255. doi: 10.1080/03009742.2020.1716992.

H Matsuoka^{1

2}, D Kabata³, A Taura², T Matsui⁴, K Takahi⁵, F Hirano⁶, M Katayama⁷, A Okamoto⁸, Y Suenaga⁹, E Suematsu¹⁰, S Yoshizawa¹¹, K Ohmura¹², S Ito¹³, H Takaoka¹⁴, E Oguro¹, K Kuzuya¹, Y Okita¹, C Udagawa^{2

15}, M Yoshimura¹, S Teshigawara¹, Y Harada¹, K Isoda¹, Y Yoshida¹, S Ohshima¹, S Tohma¹⁶, Y Saeki^{1

2}

¹ Department of Rheumatology and Allergology, NHO Osaka Minami Medical Center, Kawachinagano, Japan.
² Department of Clinical Research, NHO Osaka Minami Medical Center, Kawachinagano, Japan.
³ Department of Medical Statics, Osaka City University Graduate School of Medicine, Osaka, Japan.
⁴ Department of Rheumatology, NHO Sagamihara National Hospital, Sagamihara, Japan.
⁵ Department of Orthopedics and Rheumatology, NHO Osaka Toneyama Medical Center, Toyonaka, Japan.
⁶ Department of Internal Medicine, NHO Asahikawa Medical Center, Asahikawa, Japan.
⁷ Department of Rheumatology, NHO Nagoya Medical Center, Nagoya, Japan.
⁸ Department of Rheumatology, NHO Himeji Medical Center, Himeji, Japan.
⁹ Department of Rheumatology, NHO Beppu Medical Center, Beppu, Japan.
¹⁰ Department of Rheumatology, NHO Kyushu Medical Center, Fukuoka, Japan.
¹¹ Department of Rheumatology, NHO Fukuoka National Hospital, Fukuoka, Japan.
¹² Department of Rheumatology and Clinical Immunology, Kyoto University, Kyoto, Japan.
¹³ Department of Rheumatology, Niigata Rheumatic Center, Niigata, Japan.
¹⁴ Section of Internal Medicine and Rheumatology, Kumamoto Shinto General Hospital, Kumamoto, Japan.
¹⁵ Department of Molecular Chemistry, Faculty of Pharmacy, Osaka Ohtani University, Tondabayashi, Osaka, Japan.
¹⁶ Department of Rheumatology, NHO Tokyo National Hospital, Tokyo, Japan.

No abstract available

Publication types